Global growth equity investor Verlinvest has partnered with Sinomedica, a Swiss group of acupuncture centres.
Sinomedica is pioneering a science-based approach to medical acupuncture that enables a range of treatments and applications, including to tackle obesity. This investment from Verlinvest will help Sinomedica to accelerate growth in its existing home market of Switzerland and into new European markets, as it capitalises on increasing interest in the acupuncture field.
